Skip to content

Dose-response Evaluation of Massage Therapy Intervention in the Patients with Cancer

Dose-response Evaluation of Massage Therapy for Controlling Pain, Fatigue and Sleep Disorder in the Adult Patients with Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150302021307N5
Enrollment
273
Registered
2021-08-11
Start date
2021-08-11
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pain. Condition 2: Sleep disorder. Condition 3: Fatigue. Other chronic pain Sleep disorders not due to a substance or known physiological condition Chronic fatigue, unspecified

Interventions

Intervention 1: Control group: will receive routine care in addition to a short visit by a nurse (2 sessions per week for four weeks) to ask about the course of their illness. Intervention 2: First in

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Adults 18 to 64 years of age Reporting all three symptoms of pain, fatigue, and sleep disorder with at least two of the three rated = 4 in the last 24-hour Being currently on a chemotherapy regimen or have recently been on chemotherapy. Being at cancer stage I to IV

Exclusion criteria

Exclusion criteria: Platelet count less than 15,000 per cubic millimeter Existence of underlying diseases such as diabetes, peripheral neuropathy disease, etc. Skin disorders in massage area Known pain, fatigue and sleep disorders that are not caused by cancer and or its treatments Receiving any type of complementary medicine methods during the trial or within the last three months

Design outcomes

Primary

MeasureTime frame
Fatigue intensity. Timepoint: Fatigue intensity will be measured before interventions. During the four weeks of interventions, the fatigue intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the fatigue intensity will be measured at the end of each week. Totally, fatigue intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale.;Sleep disorder intensity. Timepoint: Sleep disorder intensity will be measured before interventions. During the four weeks of interventions, the sleep disorder intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the sleep disorder intensity will be measured at the end of each week. Totally, sleep disorder intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale.;Intensity of symptom cluster of pain, fatigue and sleep disorder. Timepoint: Nine times from baseline to endpoint of follow-up. Method of measurement: Symptom cluster intensity will be measured using pain, fatigue, and sleep disturbance items. The mean scores of the three symptoms will be calculated as the symptom cluster intensity.;Pain intensity. Timepoint: Pain intensity will be measured before interventions. During the four weeks of interventions, the pain intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the pain intensity will be measured at the end of each week. Totally, pain intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale.

Secondary

MeasureTime frame
Analgesic received. Timepoint: Analgesic received will be measured before interventions. During the four weeks of interventions will be measured at the end of each week of study. Also, during the four weeks of follow-up will be measured at the end of each week. Totally, analgesic received will be measured for 9 times. Method of measurement: The analgesic received in the last 24 hours will be documented by the patient in the booklet.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Miladinia

Ahvaz University of Medical Sciences

miladinia.m@ajums.ac.ir+98 61 3733 3333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026